New computer method aims to perfect drug doses for transplant patients
NCT ID NCT06063213
Summary
This study is testing a personalized computer program designed to help doctors find the best dose of anti-rejection drugs for people who have received a liver transplant. It aims to better balance the risk of the body rejecting the new organ against the side effects of the medication. The study will follow 40 transplant patients for six months to see if this personalized approach leads to fewer rejection episodes and infections.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRANSPLANT COMPLICATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Florida
Gainesville, Florida, 32608, United States
Conditions
Explore the condition pages connected to this study.